Compare Ishares Msci Spain ETF (EWP) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Spain ETF vs Globus Medical Inc. Class A Common Stock — how do they compare? Ishares Msci Spain ETF trades at $57.9 (market cap $2.31B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 4.4× Ishares Msci Spain ETF's market cap, and Ishares Msci Spain ETF is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Spain ETF for 41 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| EWP | GMED | |
|---|---|---|
Market Cap | $2.31B | $10.25B |
Volume | 302,484 | 1,108,124 |
Sector | Broad Market / Factor | Health |
52-Week High | $63.23 | $96.82 |
52-Week Low | $48.95 | $58.33 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | — | $9.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWP trades at $58.34, up 0.52% on the day, with a bearish technical signal driven by moving averages. The stock faces resistance at $59 and support at $58. Key financial ratios are unavailable, limiting fundamental clarity. Recent news highlights European market resilience amid ECB rate hikes and energy-driven inflation pressures.
Outlook is cautious due to bearish technicals and macroeconomic headwinds from ECB tightening. Investment opportunity hinges on Spain's equity valuation appeal, but risks include eurozone economic sentiment slippage and sustained inflation. Investors should await updated financials for fundamental assessment.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ishares Msci Spain ETF
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
